The OPTION Clinical Trial
What is the OPTION Clinical Trial?
The OPTION Clinical Trial is a randomized controlled trial comparing the safety and effectiveness of left atrial appendage closure (LAAC) to oral anticoagulation (OAC)
therapy for stroke protection in post-ablation patients with atrial fibrillation.
This study involves an investigational device called the WATCHMAN FLX™*.
* Caution: The WATCHMAN FLX™ Left Atrial Appendage Closure Device is an investigational device and is not available for sale in the U.S.
©2019 Boston Scientific Corporation or its affiliates. All rights reserved.